Search - tctmd.com

Displaying 321 - 340 of 364

Sort: Relevancy | Date

News Conference News EuroPCR 2013

Paclitaxel-eluting Balloon Matches Taxus for Treating DES Restenosis

Jason Kahn

May 23, 2013

News Conference News EuroPCR 2013

COMFORTABLE-AMI: Biodegradable-Polymer DES Offers Lasting Benefit to STEMI Patients

Caitlin E. Cox

May 23, 2013

News Conference News ACC 2013

Pair of Studies Show Positive Stent Results at ACC

Yael L. Maxwell

March 08, 2013

Presentation TCT 2013

Drug-eluting stent with biodegradable polymer in patients with STEMI – short and long term outcomes: data from e-NOBORI and NOBORI 2 trials

Presenter: Andres I?iguez, Farzin FATH-ORDOUBADHI, Isabel Calvo Cebollero, Albrecht Els?sser, Iskandar Atmowihardjo, Jorge Gaspar, Maciej Lesiak, Kai OPPENL?NDER, Nguyen Quang Ngoc, Ariel Roguin, Nicos Spyrou

January 31, 2013

News Daily News

Longer Ischemic Times in Women with STEMI Due to Age, Comorbidities

Yael L. Maxwell

December 05, 2012

News Daily News

BELLO: Drug-Coated Balloons Take on De Novo Lesions vs. DES

Caitlin E. Cox

November 15, 2012

News Daily News

BELLO: Balones recubiertos de Fármacos contra Lesiones De Novo frente a SLF

Caitlin E. Cox

November 15, 2012

Presentation TCT 2012

DES vs. BMS in STEMI: Why Is This Such a Difficult Decision?

Presenter: Giuseppe De Luca

October 22, 2012

News Daily News

Los Balones liberadores de Fármacos arrojan Resultados Positivos en el Tratamiento de la Reestenosis intra stent

Jason Kahn

October 05, 2012

News Daily News

Drug-eluting Balloons Show Positive Results in Treating In-stent Restenosis

Jason Kahn

October 05, 2012

News Daily News

Un Registro Coreano Confirma la Superioridad de los Stents liberadores de Everolimus sobre los de Zotarolimus

September 19, 2012

News Daily News

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

September 19, 2012

News Conference News ESC 2012

OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon

Caitlin E. Cox

August 29, 2012

News Conference News ESC 2012

Stent Thrombosis Surprise: Rates Low, Similar for Endeavor and Cypher at 3 Years

August 27, 2012

News Conference News ESC 2012

Survey Reveals Improvements, Gaps in Primary PCI Access Across Europe

Jason Kahn

August 26, 2012

News Daily News

Xience V Noninferior to Cypher for Primary PCI

July 24, 2012

News Conference News EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Caitlin E. Cox

May 22, 2012

Presentation EuroPCR 2012

APPOSITION III: Evaluation of the STENTYS self-apposing bare and drug-eluting stent in 1000 STEMI patients in a real-life setting: in-hospital and 30-day outcomes

Presenter: 166648|giovanni amoroso

May 18, 2012

News Conference News EuroPCR 2012

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

Caitlin E. Cox

May 17, 2012

News Conference News EuroPCR 2012

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Jason Kahn

May 15, 2012

Advertisement

Paclitaxel-eluting Balloon Matches Taxus for Treating DES Restenosis

COMFORTABLE-AMI: Biodegradable-Polymer DES Offers Lasting Benefit to STEMI Patients

Pair of Studies Show Positive Stent Results at ACC

Drug-eluting stent with biodegradable polymer in patients with STEMI – short and long term outcomes: data from e-NOBORI and NOBORI 2 trials

Longer Ischemic Times in Women with STEMI Due to Age, Comorbidities

BELLO: Drug-Coated Balloons Take on De Novo Lesions vs. DES

BELLO: Balones recubiertos de Fármacos contra Lesiones De Novo frente a SLF

DES vs. BMS in STEMI: Why Is This Such a Difficult Decision?

Los Balones liberadores de Fármacos arrojan Resultados Positivos en el Tratamiento de la Reestenosis intra stent

Drug-eluting Balloons Show Positive Results in Treating In-stent Restenosis

Un Registro Coreano Confirma la Superioridad de los Stents liberadores de Everolimus sobre los de Zotarolimus

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon

Stent Thrombosis Surprise: Rates Low, Similar for Endeavor and Cypher at 3 Years

Survey Reveals Improvements, Gaps in Primary PCI Access Across Europe

Xience V Noninferior to Cypher for Primary PCI

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

APPOSITION III: Evaluation of the STENTYS self-apposing bare and drug-eluting stent in 1000 STEMI patients in a real-life setting: in-hospital and 30-day outcomes

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content